WeBSurg, the e-surgical reference of Laparoscopic surgery
Clinical Case
CONN'S ADENOMAD Mutter , MD , PhD , Hôpitaux Universitaires de Strasbourg, Strasbourg, France 1. DescriptionThis case report describes a young patient who presents with hypertension resistant to medical therapy, secondary to a Conn's adenoma. 2. PatientMale, 36-year-old 3. Past medical historyMedical: Hypertension, smoking Surgical: None 4. History of present illnessThe patient presents with hypertension for 5-6 years. Recently, the hypertension became unstable requiring 4 drug therapies and frequent antihypertensive dosage adjustments. This is associated with frequent headaches, easy fatigability and lower extremity cramps. Physical examination was within normal limits. 5. Clinical progressionDiagnosis: Conn syndrome secondary to a left adrenal adenoma 6. Physical examinationPotassium: 3.0 (3.6-5.2) Renin supine: <2.5 ng/L (3.6-20.1 ng/L) Renin upright: <2.5 ng/L (5.1-38.7 ng/L) Aldosterone supine: 1053 pmol/L (N<477) Aldosterone upright: 996 pmol/L (N<985) Cortisol, metanephrines et normetanephrines: N 7. CT scanLeft adrenal lesion measuring 2.5 cm in diameter. 8. ScintigraphyIodonorcholesterol scintigraphy: left adrenal localization 9. Surgical procedureIntervention: laparoscopic adrenalectomy. 10. DiscussionPrimary aldosteronism was thought to be a rare cause of hypertension (1-2%). However, with improved screening methodologies, it appears that primary aldosteronism is the most common form of secondary hypertension. It is twice as common in females than in males. Patients with hypertension and hypokalemia and most patients with treatment-resistant hypertension should undergo screening for primary aldosteronism. A random and ambulatory ratio of plasma aldosterone concentration (ng/dl) to plasma renin activity (ng/ml per hour) >20 and a plasma aldosterone concentration >15 ng/dl is a positive screen for primary aldosteronism. Primary aldosteronism must be confirmed by demonstrating inappropriate aldosterone secretion with either the intravenous saline suppression test or measurement of 24-hour urinary aldosterone while on a high-sodium diet. The 2 major subtypes of primary aldosteronism are unilateral aldosterone-producing adenoma and bilateral idiopathic hyperplasia. Patients with aldosterone-producing adenoma are usually treated with unilateral adrenalectomy, and patients with idiopathic hyperplasia are treated medically. The subtype evaluation may require one or more tests, the first of which is imaging the adrenals with computed tomography (CT). When CT reveals a solitary unilateral macro-adenoma (>1 centimeter) and normal contralateral adrenal morphology in a patient with primary aldosteronism, unilateral laparoscopic adrenalectomy has become the modality of choice due to its efficacy and low morbidity . However, in many cases, CT imaging may reveal normal-appearing adrenals or ambiguous findings. In such cases we advocate the use of Iodonorcholesterol scanning which may help localize the lesion in 50-70% of cases. Pre-imaging treatment with dexamethasone to reduce ACTH secretion improves the sensitivity of the test. Adrenal venous sampling can be helpful in solving these clinical dilemmas if the above imaging modalities are negative and localizes the lesion to one side or the other in 80% of cases. The high incidence of adrenal vein thrombosis following sampling has led to a decrease in the use of this technique. 11. References
|

English ▼
Français
Español
Portuguese
日本
繁體中文
























